化学制药中报:恒瑞医药净利润居首 百济神州从亏损走向盈利

21世纪经济报道
Sep 05, 2025

记者 李森2025 年上半年,医药行业强者恒强,153 家化学制药上市公司中,6 家营收超百亿元,行业整体营收增幅分化但多数正增长,盈利能力与成长性各异。其中头部企业多数稳健增长,如恒瑞医药、新和成、华东医药营收净利双增;而百济神州更是实现从长期亏损到首次半年度盈利的转变,市值登顶 A 股医药股榜首。6家化学制药上市公司上半年营收超百亿元2025年上半年,医药行业整体呈现强者恒强态势,龙头企业凭借...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10